1.
Chinese Journal of Nuclear Medicine and Molecular Imaging
;
(6): 134-137, 2018.
Article
Dans Chinois
| WPRIM
| ID: wpr-708831
Résumé
Radioimmunotherapy (RIT) is often used as an adjuvant therapy or consolidation therapy for cancer due to its relative high specificity and minimized radiation damage to non-targeted organs.The progress of RIT in solid tumors was slow,however,it has been developed quickly recently especially in elimination of residual micro-tumor lesions due to the application of α radionuclide,the progress in antibody preparation,and the implementation of new therapeutic strategies.